Biotechnology firm raises £10m
- On September 9, 2021
- By GrowthInvest Marketing
A Nottingham-based company developing a range of orthobiologics has raised £10m through a series A funding round.
The investment into Locate Bio consists of a direct investment from Mercia Asset Management of £1.6m, alongside £4m from Mercia’s third party managed funds, which included EIS and VCT capital, together with £3m from BGF and £1.4m from other syndicate partners.
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest